CID 155924814

3-[(e)-[4-(5-ethylsulfanyl-1,3,4-oxadiazol-2-yl)phenyl]azo]-4-hydroxy-chromen-2-one

Structural Information

Molecular Formula
C19H14N4O4S
SMILES
CCSC1=NN=C(O1)C2=CC=C(C=C2)N=NC3=C(C4=CC=CC=C4OC3=O)O
InChI
InChI=1S/C19H14N4O4S/c1-2-28-19-23-22-17(27-19)11-7-9-12(10-8-11)20-21-15-16(24)13-5-3-4-6-14(13)26-18(15)25/h3-10,24H,2H2,1H3
InChIKey
LLRAMYRKNWOONK-UHFFFAOYSA-N
Compound name
3-[[4-(5-ethylsulfanyl-1,3,4-oxadiazol-2-yl)phenyl]diazenyl]-4-hydroxychromen-2-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

394.07358 Da
Monoisotopic Mass

4.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 395.080856 192.1
[M+Na]+ 417.062798 204.3
[M-H]- 393.066304 204.7
[M+NH4]+ 412.107403 201.7
[M+K]+ 433.036738 200.8
[M+H-H2O]+ 377.070840 182.5
[M+HCOO]- 439.071781 213.4
[M+CH3COO]- 453.087431 204.1
[M+Na-2H]- 415.048246 197.5
[M]+ 394.07303142 202.0
[M]- 394.07412858 202.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.